Defective nitric oxide effector functions lead to extreme susceptibility of Trypanosoma cruzi-infected mice deficient in gamma interferon receptor or inducible nitric oxide synthase

Infection and Immunity

Volumn 66, Issue 3, 1998, Pages 1208-1215

  Hölscher, Christoph ^a,b   Köhler, Gabriele ^a   Müller, Uwe ^a,b   Mossmann, Horst ^a   Schaub, Günter A ^b   Brombacher, Frank ^a,c,d  

^a UNIVERSITY OF FREIBURG   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON RECEPTOR; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CHAGAS DISEASE; HOST SUSCEPTIBILITY; IMMUNE DEFICIENCY; INFECTION RISK; INFECTION SENSITIVITY; LYMPHOCYTE DIFFERENTIATION; MACROPHAGE FUNCTION; MOUSE; NONHUMAN; PARASITE VIRULENCE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS;

EID: 0031913243     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.3.1208-1215.1998     Document Type: Article

References (49)

1. Abrahamsohn, I. A., and R. L. Coffman. 1996. Trypanosoma cruzi-IL-10, TNF, IFN-gamma, and IL-12 regulate innate and acquired-immunity to infection. Exp. Parasital. 84:231-244.
2. Aliberti, J. C., M. A. Cardoso, G. A. Martins, R. T. Gazzinelli, L. Q. Vieira, and J. S. Silva. 1996. Interleukin-12 mediates resistance to Trypanosoma cruzi in mice and is produced by murine macrophages in response to live trypomastigotes. Infect. Immun. 64:1961-1967.
3. Barrera, L. F., I. Kramnik, E. Skamene, and D. Radzioch. 1994. Nitrite production by macrophages derived from BCG-resistant and -susceptible congenic mouse strains in response to IFN-gamma and infection with BCG. Immunology 82:457-464.
4. Beckman, J. S. 1991. The double-edged role of nitric oxide in brain function and superoxide-mediated injury. J. Dev. Physiol. 15:53-59.
5. Biron, C. A., and R. T. Gazzinelli. 1995. Effects of IL-12 on immune responses to microbial infections: a key mediator in regulating disease outcome. Curr. Opin. Immunol. 7:485-496.
6. Brombacher, F., and M. Kopf. 1996. Innate versus acquired immunity in listeriosis. Res. Immunol. 147:505-511.
7. Cardillo, F., R. P. Falcao, M. A. Rossi, and J. Mengel. 1993. An age-related gamma delta T cell suppressor activity correlates with the outcome of autoimmunity in experimental Trypanosoma cruzi infection. Eur. J. Immunol. 23:2597-2605.
8. Cardillo, F., J. C. Voltarelli, S. G. Reed, and J. S. Silva. 1996. Regulation of Trypanosoma cruzi infection in mice by gamma interferon and interleukin 10: role of NK cells. Infect. Immun. 64:128-134.
9. Cunningham, D. S., and R. E. Kuhn. 1980. Trypanosoma cruzi-induced suppression of the primary immune response in murine cell cultures to T-cell-dependent and -independent antigens. J. Parasitol. 66:16-27.
10. Curotto de Lafaille, M. A., L. C. Barbosa de Oliveira, G. C. Lima, and I. A. Abrahamsohn. 1990. Trypanosoma cruzi: maintenance of parasite-specific T cell responses in lymph nodes during the acute phase of the infection. Exp. Parasitol. 70:164-174.
11. Dai, W. D., G. Köhler, and F. Brombacher. 1997. Both innate and acquired immunity to Listeria monocytogenes infection are increased in IL-10 deficient mice. J. Immunol. 158:2259-2267.
12. Dai, W. J., W. Bartens, G. Kohler, M. Hufnagel, M. Kopf, and F. Brombacher. 1997. Impaired macrophage listericidal and cytokine activities are responsible for the rapid death of Listeria monocytogenes-infected IFN-gamma receptor-deficient mice. J. Immunol. 158:5297-5304.
13. Denicola, A., H. Rubbo, D. Rodriguez, and R. Radi. 1993. Peroxynitrite-mediated cytotoxicity to Trypanosoma cruzi. Arch. Biochem. Biophys. 304: 279-286.
14. Fehr, T., G. Schoedon, B. Odermatt, T. Holtschke, M. Schneemann, M. F. Bachmann, T. W. Mak, I. Horak, and R. M. Zinkernagel. 1997. Crucial role of interferon consensus sequence binding protein, but neither of interferon regulatory factor 1 nor of nitric oxide synthesis for protection against murine listeriosis. J. Exp. Med. 185:921-931.
15. Flesch, I., B. Ecker, and E. Ferber. 1984. Acyltransferase-catalyzed cleavage of arachidonic acid from phospholipids and transfer to lysophosphatides in macrophages derived from bone marrow. Comparison of different donor-and acceptor substrate combinations. Eur. J. Biochem. 139:431-437.
16. Frosch, S., S. Kraus, and B. Fleischer. 1996. Trypanosoma cruzi is a potent inducer of interleukin-12 production in macrophages. Med. Microbiol. Immunol. 185:189-193.
17. Gazzinelli, R. T., S. Hieny, T. A. Wynn, S. Wolf, and A. Sher. 1993. Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts. Proc. Natl. Acad. Sci. USA 90:6115-6119.
18. Gazzinelli, R. T., I. P. Oswald, S. L, James, and A. Sher. 1992. IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages. J. Immunol. 148:1792-1796.
19. Golden, J. M., and R. L. Tarleton. 1991. Trypanosoma cruzi: cytokine effects on macrophage trypanocidal activity. Exp. Parasitol. 72:391-402.
20. Hsieh, C. S., S. E. Macatonia, C. S. Tripp, S. F. Wolf, A. O'Garra, and K. M. Murphy. 1993. Development of T(H)1 CD4(+) T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547-549.
21. Huang, S., W. Hendriks, A. Althage, S. Hemmi, H. Bluethmann, R. Kamijo, J. Vilcek, R. M. Zinkernagel, and M. Aguet. 1993. Immune response in mice that lack the interferon-gamma receptor. Science 259:1742-1745.
22. Kamijo, R., H. Harada, T. Matsuyama, M. Bosland, J. Gerecitano, D, Shapiro, J. Le, S. I. Koh, T. Kimura, S. J. Green, T. W. Mak, T. Taniguchi, and J. Vilcek. 1994. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science 263:1612-1615.
23. -/- mice. J. Immunol. 156:636-643.
24. Kopf, M., F. Brombacher, G. Kienzle, K.-H. Widmann, K. Lefranc, C. Humborg, B. Ledermann, and W. Solbach. 1996. IL-4-deficient mice without elevating Th1 responses resist infection with Leishmania major. J. Exp. Med. 184:1127-1136.
25. Kopf, M., G. LeGros, A. Coyle, M. Kosco-Vilbois, and F. Brombacher. 1995. Immune responses of IL-4, IL-5, IL-6 deficient mice. Immunol. Rev. 148: 45-69.
26. Lima, E. C. S., I. Garcia, M.-H. Vicentelli, P. Vassalli, and P. Minoprio. 1997. Evidence for a protective role of tumor necrosis factor in the acute phase of Trypanosoma cruzi infection in mice. Infect. Immun. 65:457-465.
27. Lopes, M. F., and G. A. Dos Reis. 1994. Trypanosoma cruzi-induced immunosuppression: blockade of costimulatory T-cell responses in infected hosts due to defective T-cell receptor-CD3 functioning. Infect. Immun. 62:1484-1488.
28. MacMicking, J. D., C. Nathan, G. Hom, N. Chartrain, D. S. Fletcher, M. Trumbauer, K. Stevens, Q. W. Xie, K. Sokol, N. Hutchinson, et al. 1995. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 81:641-650.
29. McCabe, R. E., S. G. Meagher, and B. T. Mullins. 1991. Endogenous interferon-gamma, macrophage activation, and murine host defense against acute infection with Trypanosoma cruzi. J. Infect. Dis. 163:912-915.
30. Nabors, G. S., and R. L. Tarleton. 1991. Differential control of IFN-gamma and IL-2 production during Trypanosoma cruzi infection. J. Immunol. 146: 3591-3598.
31. Petray, P., M. E. Rottenberg, S. Grinstein, and A. Orn. 1994. Release of nitric oxide during the experimental infection with Trypanosoma cruzi. Parasite Immunol. 16:193-199.
32. Radi, R., J. S. Beckman, K. M. Bush, and B. A. Freeman. 1991. Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of Superoxide and nitric oxide. Arch. Biochem. Biophys. 288:481-487.
33. Reed, S. G. 1988. In vivo administration of recombinant IFN-gamma induces macrophage activation and prevents acute disease, immune suppression, and death in experimental Trypanosoma cruzi infections. J. Immunol. 140:4342-4347.
34. Reed, S. G., D. L. Pihl, and K. H. Grabstein. 1989. Immune deficiency in chronic Trypanosoma cruzi infection. Recombinant IL-1 restores Th function for antibody production. J. Immunol. 142:2067-2071.
35. Rockett, K. A., M. M. Awburn, E. J. Rockett, and I. A. Clark. 1994. Tumor necrosis factor and interleukin-1 synergy in the context of malaria pathology. Am. J. Trop. Med. Hyg. 50:735-742.
36. Rottenberg, M., C. Lindqvist, A. Koman, E. L. Segura, and A. Orn. 1989. Modulation of both interleukin 2 receptor expression and interleukin 2 production during experimental murine Trypanosoma cruzi infection. Scand. J. Immunol. 30:65-72.
37. Rottenberg, M. E., E, Castanos-Velez, R. de Mesquita, O. G. Laguardia, P. Biberfeld, and A. Orn. 1996. Intracellular co-localization of Trypanosoma cruzi and inducible nitric oxide synthase (iNOS): evidence for dual pathway of iNOS induction. Eur. J. Immunol. 26:3203-3213.
38. Russo, M., N. Starobinas, P. Minoprio, A. Coutinho, and M. Hontebeyrie-Joskowicz. 1988. Parasitic load increases and myocardial inflammation decreases in Trypanosoma cruzi-infected mice after inactivation of helper T cells. Ann. Inst. Pasteur Immunol. 139:225-236.
39. Scharton, K. T., T. A. Wynn, E. Y. Denkers, S. Bala, E. Grunvald, S. Hieny, R. T. Gazzinelli, and A. Sher. 1996. In the absence of endogenous IFN-gamma, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection. J. Immunol. 157:4045-4054.
40. Scharton-Kersten, T. M., G. Yap, J. Magram, and A. Sher. 1997. Inducible nitric oxide is essential for host control of persistent but not acute infection with the intracellular pathogen Toxoplasma gondii. J. Exp. Med. 185:1261-1273.
41. Snapper, C. M., and W. E. Paul. 1987. Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 236:944-947.
42. Stenger, S., N. Donhauser, H. Thuring, M. Rollinghoff, and C. Bogdan. 1996. Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase. J. Exp. Med. 183:1501-1514.
43. Tarleton, R. L. 1990. Depletion of CD8+ T cells increases susceptibility and reverses vaccine-induced immunity in mice infected with Trypanosoma cruzi. J. Immunol. 144:717-724.
44. Taylor-Robinson, A. W., F. Y. Liew, A. Severn, D. Xu, S. J. McSorley, P. Garside, J. Padron, and R. S. Phillips. 1994. Regulation of the immune response by nitric oxide differentially produced by T helper type 1 and T helper type 2 cells. Eur. J. Immunol. 24:980-984.
45. Torrico, F., H. Heremans, M. T. Rivera, E. Van Marck, A. Billiau, and Y. Carlier. 1991. Endogenous IFN-gamma is required for resistance to acute Trypanosoma cruzi infection in mice. J. Immunol. 146:3626-3632.
46. Van der Broek, M. F., U. Mueller, S. Huang, R. M. Zinkernagel, and M. Aguet. 1995. Immune defence in mice lacking type I and/or type II Interferon receptors. Immunol. Rev. 148:5-18.
47. Vespa, G. N., F. Q. Cunha, and J. S. Silva. 1994. Nitric oxide is involved in control of Trypanosoma cruzi-induced parasitemia and directly kills the parasite in vitro. Infect. Immun. 62:5177-5182.
48. Wei, X. Q., I. G. Charles, A. Smith, J. Ure, G. J. Feng, F. P. Huang, D. Xu, W. Muller, S. Moncada, and F. Y. Liew. 1995. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375:408-411.
49. Yoshida, A., Y. Koide, M. Uchijima, and T. O. Yoshida. 1995. Dissection of strain difference in acquired protective immunity against Mycobacterium bovis Calmette-Guerin bacillus (BCG). Macrophages regulate the susceptibility through cytokine network and the induction of nitric oxide synthase. J. Immunol. 155:2057-2066.